Nicotine-Midazolam Mixture for Eye Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Heavy smokers undergoing cataract removal and artificial lens implantation surgery often exhibit twitching and fidgeting under sedation with midazolam, necessitating higher-risk medical procedures to stabilize the eye, which poses risks to vision and surgical complications.
Innovation Solution
A mixture of midazolam sedative and nicotine, in a ratio of 2:1 to 1:2 by volume, is administered intravenously to reduce twitching and fidgeting, allowing for stable eye surgery without the need for additional high-risk interventions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If midazolam sedative alone is used for cataract surgery patients, then the sedation is simple and safe, but heavy smokers still exhibit twitching and fidgeting causing eye movement
Solution Approach 1:
The patent combines midazolam sedative with nicotine in a single injectable composition. The nicotine component specifically addresses twitching and fidgeting in heavy smokers, while midazolam provides general sedation. This merged formulation resolves the eye stability issue without requiring complex multiple-procedure sedation regimens.
Solution Approach 2:
The patent modifies the sedation composition by adding nicotine to the midazolam formulation. This parameter change in the drug composition specifically targets the physiological response (twitching and fidgeting) observed in heavy smokers, thereby improving eye stability without increasing procedural complexity.
2Reliability
If higher-risk medical procedures are used to completely sedate the patient, then eye movement is completely prevented, but surgical risk and risk of vision loss increase
Solution Approach 1:
By merging midazolam and nicotine into a single injectable composition, the patent achieves complete eye stabilization without requiring higher-risk alternative procedures. The nicotine component specifically suppresses twitching and fidgeting, while midazolam provides sedation, together preventing eye movement with minimal surgical risk.
Solution Approach 2:
The patent converts the harmful effect of nicotine (typically associated with health risks) into a beneficial therapeutic effect by using it to suppress twitching and fidgeting in smokers during surgery. This transforms a previously harmful substance into a useful component that prevents eye movement without the need for high-risk procedures.
3Ease of operation
If midazolam is used for sedation, then the administration is simple, but twitching and fidgeting persist in heavy smokers during surgery
Solution Approach 1:
The patent merges midazolam and nicotine into a single injectable composition that maintains simple administration while adding eye stabilization capability. The combination is administered as one injection, preserving ease of operation, while the nicotine component specifically eliminates twitching and fidgeting in heavy smokers, thereby improving eye stability.
Data Source
AI summary
A drug for sedating a patient, and especially a smoker, during eye surgery. The drug includes a sedative such as midazolam in a mix with nicotine. The mixture is injected into the patient prior to the eye surgery.